Brief: Novakand Pharma CEO Peter Selin Resigns
23/09/2025 14:01
Sept 23 (Reuters) - Kancera AB KANC.ST: PETER SELIN RESIGNS AS CEO OF NOVAKAND PHARMA IN MUTUAL AGREEMENT WITH THE BOARD Source text: ID:nMFNc1fBq4 Further company coverage: KANC.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Novakand Pharma AB
See all newsBrief: Nasdaq Decides To Delist Novakand From First North Growth Market
Brief: Novakand Pharma Extends Peter Selin's CEO Employment
Brief: Novakand Board Proposes New Business Direction, Relisting
Brief: Novakand Pharma Evaluates Options After Decision Not To Execute Reverse Take Over
Brief: Nasdaq Rejects Novakand's Application For Continued Listing